Edible Garden AG Incorporated: Detailed Investor Update from 2025 10-K/A Filing

Key Highlights and Insights for Investors

• Amendment to Annual Report: Edible Garden AG Incorporated (“Edible Garden” or the “Company”) has filed Amendment No. 1 to its Annual Report on Form 10-K (10-K/A) for the fiscal year ended December 31, 2025. This amendment was necessary as the Board has not yet set the date for the 2026 annual meeting of shareholders, resulting in the Company filing required Part III information directly instead of via proxy statement.
• Disclosure of Key Governance Items: The amendment includes detailed disclosures on Directors, Executive Officers, Corporate Governance, Executive Compensation, Security Ownership, Certain Relationships and Related Transactions, Director Independence, and Principal Accountant Fees.
• Current Filing Status: The Company confirms it is a non-accelerated filer, a smaller reporting company, and an emerging growth company. It is not a shell company.
• Compliance: The Company has complied with all reporting obligations, submitted all required Interactive Data Files, and filed all reports for the past 12 months. No internal control attestation report by the auditor was filed, and there were no corrections or restatements of prior financial statements.
• Security Information:
  • Common Stock, par value \$0.0001, trading symbol EDBL, listed on Nasdaq.
  • Warrants to purchase Common Stock, trading symbol EDBLW, also listed on Nasdaq.
  • As of June 30, 2025, there were 5,213,691 shares of Common Stock outstanding.
• Equity Compensation Plans:
  • 98,825 options/warrants outstanding under approved plans with a weighted average exercise price of \$10.70.
  • 831,270 shares remaining available for future issuance under equity compensation plans (777,862 under the 2025 Plan and 53,408 under the 2022 Plan).
• Executive Compensation:
  • Details are provided on bonuses, stock awards, option awards, and other forms of compensation for key executive officers.
  • Interim Chief Financial Officer compensation noted for 2024 was \$240,000.
• Related Party Transactions:
  • Settled accrued preferred return obligations through the issuance of 459 additional shares of Series B Preferred Stock with an aggregate stated value of \$459,000.
  • Exchanged 175 shares of Series B Preferred Stock for common stock during the year.
  • Written policy adopted requiring audit committee approval for all related party transactions exceeding \$120,000.
• Director Independence:
  • Board members Pamela DonAroma, Mathew McConnell, M. Naidrich, and Ryan Rogers are considered independent under Nasdaq standards.
  • Regular executive sessions for independent directors are held to ensure open discussion and oversight.
• Corporate Governance and Ethics:
  • The Board has adopted a Code of Ethics applicable to directors, officers, and employees. Amendments and waivers will be disclosed on the Company’s website.
  • Insider trading policy restricts trading to open window periods and prohibits trading while in possession of material non-public information.
• Audit and Fees:
  • Audit fees for 2025 totaled \$451,900, and audit-related fees were \$406,900.
  • Audit committee oversight of all audit and non-audit services; no audit firm attestation on internal controls as required for larger filers.
• Exhibits and Incorporation by Reference:
  • Extensive listing of material contracts, equity plans, warrant agreements, and certificate amendments filed as exhibits and available for review on the SEC website.

Potential Price-Sensitive Information for Shareholders

• Delay in Annual Meeting and Proxy Filing: The Board’s delay in setting the annual meeting date may impact the timing of shareholder votes and could signal uncertainty or transition in governance.
• Equity Incentive Plans: The large number of shares available for future issuance and the relatively high exercise price of outstanding options could impact dilution and future share value.
• Related Party Transactions: Settlement of preferred stock obligations and exchanges involving significant dollar amounts may affect capital structure and shareholder returns.
• Governance and Ethics Policies: Enhanced disclosure on ethics and insider trading policies may improve investor confidence but also signals heightened regulatory oversight.
• Audit Fees and Oversight: The high audit and audit-related fees, and the absence of an auditor attestation on internal controls, may affect perceptions of financial controls and risk.

Investor Takeaways

• The Company remains compliant and transparent in its filings but faces timing issues regarding shareholder meetings and proxy statements.
• Dilution risk remains due to large available shares under equity compensation plans; investors should monitor future issuances.
• Governance and related party transactions are tightly controlled but involve substantial sums that investors should watch.
• Audit fees and governance policies may indicate increased focus on compliance or underlying complexity in financial reporting.
• Shareholders should expect future announcements regarding the annual meeting and proxy statement, which could be material events.

Disclaimer

This article is provided for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. The Company’s filings and disclosures may contain risks and uncertainties not fully covered in this summary.

View Edible Garden AG Inc Historical chart here